Welcome to LookChem.com Sign In|Join Free
  • or
3-Chloroisonicotinic acid is a chemical compound with the molecular formula C6H4ClNO2, derived from isonicotinic acid with a chlorine atom substituted at the 3-position of the pyridine ring. It is a white solid with a slightly acidic nature, and its properties make it a valuable ingredient in the manufacturing of various products.

88912-27-0

Post Buying Request

88912-27-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88912-27-0 Usage

Uses

Used in Organic Synthesis:
3-Chloroisonicotinic acid is used as a building block in organic synthesis for the creation of various chemical compounds. Its unique structure and reactivity make it a versatile component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
3-Chloroisonicotinic acid is used as a key intermediate in the development of new pharmaceuticals. Its potential applications include the synthesis of antibiotics, anti-inflammatory drugs, and other therapeutic agents. Its ability to form complexes with metal ions also opens up possibilities for the development of metal-based drugs with unique properties and mechanisms of action.
Used in Coordination Chemistry:
3-Chloroisonicotinic acid is used as a versatile ligand in coordination chemistry, forming complexes with metal ions. These complexes have catalytic and biological relevance, making them valuable in various applications such as catalysis, sensing, and drug development. The coordination of metal ions with 3-chloroisonicotinic acid can also enhance the stability and reactivity of the resulting complexes, broadening their potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 88912-27-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,1 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 88912-27:
(7*8)+(6*8)+(5*9)+(4*1)+(3*2)+(2*2)+(1*7)=170
170 % 10 = 0
So 88912-27-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H4ClNO2/c7-5-3-8-2-1-4(5)6(9)10/h1-3H,(H,9,10)

88912-27-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (633410)  3-Chloropyridine-4-carboxylicacid  97%

  • 88912-27-0

  • 633410-1G

  • 222.30CNY

  • Detail
  • Aldrich

  • (633410)  3-Chloropyridine-4-carboxylicacid  97%

  • 88912-27-0

  • 633410-5G

  • 769.86CNY

  • Detail

88912-27-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Chloroisonicotinic Acid

1.2 Other means of identification

Product number -
Other names 3-chloropyridine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88912-27-0 SDS

88912-27-0Relevant academic research and scientific papers

Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh] isoquinolinone derivatives

Shahabi, Manochehr,Schirmer, Eva,Shanab, Karem,Leepasert, Theerachart,Ruzicka, Jana,Holzer, Wolfgang,Spreitzer, Helmut,Aicher, Babette,Schmidt, Peter,Blumenstein, Lars,Müller, Gilbert,Günther, Eckhard

, p. 1846 - 1852 (2013/04/10)

A series of indazolo[4,3-gh]isoquinolinones derivatives have been synthesized to decrease cardiotoxic side effects in comparison to Mitoxantrone. The antiproliferative effects of different side chains were investigated and tested on at least four different cell lines of cervix, ovarian, CNS, NSCLC (non-small-cell lung cancer) and colon carcinoma. In addition to antiproliferative activities, influence on cell cycle and intercalation behavior have been tested.

Antithrombotic amides

-

, (2008/06/13)

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.

Directed lithiation of unprotected pyridinecarboxylic acids: Syntheses of halo derivatives

Lazaar, Jalal,Rebstock, Anne-Sophie,Mongin, Florence,Godard, Alain,Trécourt, Fran?ois,Marsais, Francis,Quéguiner, Guy

, p. 6723 - 6728 (2007/10/03)

Deprotonation of all isomeric lithium pyridinecarboxylates and subsequent trapping with hexachloroethane or iodine afforded straightforward access to chloro- and iodopyridinecarboxylic acids, respectively. Starting from lithium 5-bromonicotinate, the introduction of an iodine atom at C4 and further halogen migration allowed the potential of this method to be extended to the synthesis of more elaborate derivatives.

Application of organolithium compounds in organic synthesis. Part 19. Synthetic strategies based on aromatic metallation. A concise regiospecific synthesis of 3-halogenated picolinic and isonicotinic acids

Epsztajn,Plotka,Grabowska

, p. 1075 - 1086 (2007/10/03)

The synthesis of the halogenated picolin- and isonicotinalides (3) and (4) via metallation (n-BuLi) of the anilides (1) and (2) and then the reaction of the generated bis-lithiated anilides with halogenating agents (CCl3-CCl3, CH2Br-CH2Br, I2) followed by subsequent acidic hydrolysis of (3) and (4), as a way of regiospecific transformation of picoline and isonicotine acids into their C3-halogenated derivatives, is described.

Synthesis of regioisomeric 6,9-(chlorofluoro)-substituted benzo[g]quinoline-5,10-diones, benzo[g]isoquinoline-5,10-diones and 6-chloro-9-fluorobenzo[g]quinoxaline-5,10-dione

Krapcho, A. Paul,Gallagher, Cynthia E.,Hammach, Abdelhakim,Ellis, Michael,Menta, Ernesto,Oliva, Ambrogio

, p. 27 - 32 (2007/10/03)

Treatment of difluoro or chloro fluoro-substituted benzyl bromides 5a-c with zinc dust in tetrahydrofuran leads to the corresponding benzylic zinc bromides 6a-c. These organometallics on treatment with chlorosubstituted heterocyclic esters 4A and 4B mediated by nickel catalysis undergo couplings to yield dihalobenzyl substituted heterocyclic esters 7Aa-c and 7Ba-c. Treatment of 4c with 6c under Pd catalysis leads to 7Cc. The acids 8, prepared by hydrolysis of these esters, with treatment of fuming sulfuric acid undergo cyclizations and oxidations to yield the desired regioisomeric dihalo-substituted heterocyclic quinones 2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88912-27-0